RheumNow

#ACR25 RA Topic Panel A focused conversation on the latest in psoriatic arthritis care — from emerging data and trea […]

In 2024, 77 pts referred to Rheum for possible PMR were ultimately Dx w/ B19 viral infx. 96% had arthralgia

Genetic Risks and Severe Cutaneous Reactions to Allopurinol jjcush@gmail.com Mon, 11/10/2025 – 17:02

New ACR 2025 Guidelines for Non-Renal Lupus jjcush@gmail.com Mon, 11/10/2025 – 16:44

There is a growing burden of #OA among middle-aged adults, rising by 123.7%, from 11.8 million in 1990 to 26.4

20-40% of Autoimmune hepatitis (AIH) is associated with other autoimmune diseases – lead by autoimmune thyroiditis, type https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Mon,

Sjogren’s disease: two drugs with positive trials Sjogren’s disease: two drugs with positive trials After several https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Mon, 11/10/2025

RETREAT study was a 12 wk RCT of Tai Chi in 178 knee OA pts Rx w/ online OA info

Off the Shelf: CAR-T Dr. Akhil Sood reports on abstract 0663 (iPSC-Derived Off-the-Shelf anti-CD19 CAR T cells Deliver https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…

AI in Fellow Recruitment: A New Dawn in Medical Education? Drs. Mrinalini Dey and Bharat Kumar abstract 2174 (Using Na

Beyond the Breakthrough: Equity and Access in CAR-T Cell Therapy for RA At #ACR25, abstract 1039, “Global Cost-Effecti https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…

“It is not the strongest of the species that survive, nor the most intelligent, but the one most responsive to

Beyond the Breakthrough: Equity and Access in CAR-T Cell Therapy for RA At #ACR25, abstract 1039 entitled, “Global https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…

IL-23 Blockade Goes Oral A new player is entering the IL-23 arena — and it’s a tablet! Icotrokinra (ICO), a

Stopping therapy in GCA At #ACR25 we saw the SELECT-GCA extension data presented in the first plenary session, looking https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg

The Interview jjcush@gmail.com Fri, 11/07/2025 – 18:11 Education/ACR/EULAR Economics Wisdom Is Featured Off Show Author Off PDQ Off

The Interview (11.7.2025) jjcush@gmail.com Fri, 11/07/2025 – 18:00

Weight Loss as a Therapeutic Goal in PsA PsA is a complex inflammatory disease often complicated by obesity, which not

IgG4: Rare, but new treatments on the horizon IgG4 is a rare autoimmune disease with excessive IgG4 immunoglobulins th https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg

Do Patients with Rheumatic Diseases ‘Weather’ the Storm? Dr. Janet Pope reports on abstract 0164 (Online Patient Surve https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…

Ianalumab Shows Phase 3 Success in Sjögren’s: Is It Clinically Meaningful? leefam59@gmail.com Fri, 11/07/2025 – 09:53

Upadacitinib: revisiting safety data in RA and GCA For the last several years, conversations about JAK inhibitors have https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…

#ACR25 Best Abstracts – Day 3 Tweeting about an ACR presentation or poster is a skill and sometimes art —

Replay of RheumNow Live 2025 – Rheumatoid Arthritis https://t.co/TMC0A11Eil https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu, 11/06/2025 – 19:15 RheumNow Dr. John Cush Replay

Accelerated Aging in Rheumatic Disease: From Biology to Lifestyle Intervention At #ACR25, the session “27M02: Nutrit https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu, 11/06/2025